Enlivex Therapeutics Ltd. - stock earnings
ENLV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.0 million USD | ? USD |
| 2023Q2 | -6.8 million USD | ? USD |
| 2023Q1 | -7.7 million USD | ? USD |
| 2022Q4 | -6.5 million USD | ? USD |
| 2022Q3 | -6.5 million USD | ? USD |
| 2022Q2 | -14.0 million USD | ? USD |
| 2022Q1 | -4.7 million USD | ? USD |
| 2021Q4 | -4.7 million USD | ? USD |
| 2021Q3 | -3.4 million USD | ? USD |
| 2021Q2 | -3.1 million USD | ? USD |
| 2021Q1 | -5.9 million USD | 2.3 million USD |
| 2020Q4 | -5.9 million USD | 2.3 million USD |
| 2020Q3 | -3.0 million USD | ? USD |
| 2020Q2 | -3.0 million USD | ? USD |
| 2020Q1 | -2.9 million USD | ? USD |
| 2019Q4 | -2.9 million USD | ? USD |
| 2019Q3 | -2.4 million USD | ? USD |
| 2019Q2 | -1.5 million USD | ? USD |
| 2019Q1 | -1.6 million USD | ? USD |
| 2018Q4 | -1.6 million USD | ? USD |
| 2018Q3 | -1.1 million USD | ? USD |
| 2018Q2 | -531000 USD | ? USD |
| 2018Q1 | -569000 USD | ? USD |
| 2017Q4 | -569000 USD | ? USD |
| 2017Q3 | -1.1 million USD | ? USD |
| 2017Q2 | -1.6 million USD | ? USD |
| 2017Q1 | -2.7 million USD | ? USD |
| 2016Q4 | -3.1 million USD | ? USD |
| 2016Q3 | -4.7 million USD | ? USD |
| 2016Q2 | -3.7 million USD | ? USD |
| 2016Q1 | -4.6 million USD | ? USD |
| 2015Q4 | -4.8 million USD | ? USD |
| 2015Q3 | -3.6 million USD | ? USD |
| 2015Q2 | -3.7 million USD | ? USD |
| 2015Q1 | -3.3 million USD | ? USD |
| 2014Q4 | -3.2 million USD | ? USD |
| 2014Q3 | -2.1 million USD | ? USD |
| 2014Q2 | -1.1 million USD | ? USD |
| 2014Q1 | -645000 USD | ? USD |
| 2013Q4 | -777000 USD | ? USD |
| 2013Q3 | -195000 USD | ? USD |
| 2013Q2 | -135000 USD | ? USD |
| 2008Q2 | ? USD | 5.6 million USD |
| 2008Q1 | ? USD | 4.4 million USD |
| 2007Q4 | ? USD | 7.1 million USD |
| 2007Q3 | ? USD | 4.5 million USD |
| 2007Q2 | ? USD | 3.8 million USD |
| 2007Q1 | ? USD | 3.3 million USD |
| 2006Q4 | ? USD | 4.3 million USD |
| 2006Q3 | ? USD | 3.2 million USD |
| 2006Q2 | ? USD | 5.7 million USD |
| 2006Q1 | ? USD | 4.0 million USD |
| 2005Q4 | ? USD | 7.2 million USD |
| 2005Q3 | ? USD | 6.0 million USD |
| 2005Q2 | ? USD | 6.6 million USD |
| 2005Q1 | ? USD | 5.6 million USD |
| 2004Q4 | ? USD | 4.8 million USD |
| 2004Q3 | ? USD | 3.4 million USD |
| 2004Q2 | 780000 USD | 2.8 million USD |
| 2004Q1 | ? USD | 3.6 million USD |
| 2003Q4 | ? USD | 2.5 million USD |
| 2003Q3 | ? USD | 2.5 million USD |
| 2003Q2 | ? USD | 4.5 million USD |
| 2003Q1 | ? USD | 4.0 million USD |
| 2002Q4 | ? USD | 2.7 million USD |
| 2002Q3 | ? USD | 5.3 million USD |
| 2002Q2 | ? USD | 5.3 million USD |
| 2002Q1 | ? USD | 4.9 million USD |
| 2001Q4 | ? USD | 4.5 million USD |
| 2001Q3 | ? USD | 4.0 million USD |
| 2001Q2 | ? USD | 2.8 million USD |
| 2001Q1 | ? USD | 2.8 million USD |
| 2000Q4 | ? USD | 2.1 million USD |
| 2000Q3 | ? USD | 1.1 million USD |
| 2000Q2 | ? USD | 155000 USD |
| 2000Q1 | ? USD | 162000 USD |
ENLV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -27.2 million USD | ? USD |
| 2022 | -42.4 million USD | ? USD |
| 2021 | -9.6 million USD | ? USD |
| 2020 | -13.9 million USD | 2.3 million USD |
| 2019 | -10.1 million USD | ? USD |
| 2018 | -4.2 million USD | ? USD |
| 2017 | -5.9 million USD | ? USD |
| 2016 | -16.0 million USD | ? USD |
| 2015 | -15.4 million USD | ? USD |
| 2014 | -7.0 million USD | ? USD |
| 2013 | -1.1 million USD | ? USD |
| 2012 | -229000 USD | ? USD |
| 2007 | ? USD | 18.7 million USD |
| 2006 | ? USD | 17.2 million USD |
| 2005 | ? USD | 25.3 million USD |
| 2004 | ? USD | 14.5 million USD |
| 2003 | ? USD | 13.5 million USD |
| 2002 | ? USD | 18.1 million USD |
| 2001 | ? USD | 14.0 million USD |
| 2000 | ? USD | 3.6 million USD |
ENLV
Price: $1.61
52 week price:
Earnings Per Share: -1.47 USD
P/E Ratio: -2.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 21300
Market Capitalization: 24.2 million